• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate (CAS No. 1053657-05-8): An Overview of Its Synthesis, Properties, and Applications in Medicinal Chemistry

Methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate (CAS No. 1053657-05-8) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of oxazoles, which are known for their wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties.

The synthesis of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate typically involves a multi-step process that begins with the reaction of 2-bromobenzaldehyde and methyl cyanoacetate to form the corresponding α-cyano ester. This intermediate is then cyclized in the presence of an acid catalyst to yield the desired oxazole derivative. The final step involves the esterification of the carboxylic acid group to form the methyl ester. This synthetic route is well-documented in the literature and has been optimized to achieve high yields and purity.

One of the key features of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate is its bromine substituent on the phenyl ring. The presence of this bromine atom not only enhances the compound's reactivity but also provides a handle for further functionalization. This makes it an attractive starting material for the synthesis of more complex molecules with diverse biological activities. Recent studies have explored the use of this compound as a building block for the development of novel pharmaceutical agents.

In terms of physical properties, methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate is a white crystalline solid with a melting point ranging from 98°C to 100°C. It is soluble in common organic solvents such as dichloromethane, ethanol, and dimethyl sulfoxide (DMSO). These solubility characteristics make it suitable for various analytical and preparative techniques.

The biological activity of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate has been extensively studied in recent years. One notable area of research is its potential as an anticancer agent. Studies have shown that this compound exhibits significant cytotoxic activity against various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action is believed to involve the inhibition of key enzymes involved in cell proliferation and survival pathways.

Another area of interest is the anti-inflammatory properties of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate. In vitro studies have demonstrated that this compound can effectively inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that it may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic properties of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate have also been investigated. Studies have shown that it has good oral bioavailability and a favorable pharmacokinetic profile, making it suitable for further development as a drug candidate. However, further research is needed to optimize its pharmacological properties and evaluate its safety profile in preclinical models.

In addition to its potential therapeutic applications, methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate has been used as a probe molecule in chemical biology studies. Its unique structure allows it to interact with specific protein targets, providing valuable insights into protein function and regulation. For example, it has been used to study the interactions between oxazoles and enzymes involved in metabolic pathways.

The environmental impact of methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate is another important consideration. While there are currently no reported environmental concerns associated with this compound, ongoing research is being conducted to ensure its safe use and disposal. This includes evaluating its biodegradability and potential effects on aquatic organisms.

In conclusion, methyl 5-(2-bromophenyl)-1,2-oxazole-3-carboxylate (CAS No. 1053657-05-8) is a promising compound with a wide range of potential applications in medicinal chemistry. Its unique structural features and biological activities make it an attractive target for further research and development. As new findings continue to emerge, this compound is likely to play an increasingly important role in the discovery and development of novel therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)